I never thought I’d someday write the sentence, “I really enjoyed that FDA meeting.” But here I am doing just that.
The topic of the meeting — regulatory implications of an emerging class of medicines to promote health by modulating the teeming microbial ecosystems that live inside each of us — may not sound like much fun, but for those of us in the field it was both enjoyable and enlightening.
Read more at: STAT
